✦ LIBER ✦

Combined Resveratrol, Quercetin, and Catechin Treatment Reduces Breast Tumor Growth in a Nude Mouse Model

✍ Scribed by Schlachterman, Alexander; Valle, Felix; Wall, Kristin M.; Azios, Nicolas G.; Castillo, Linette; Morell, Lymar; Washington, A. Valance; Cubano, Luis A.; Dharmawardhane, Surangani F.

Book ID: 122874553
Publisher: Elsevier
Year: 2008
Tongue: English
Weight: 635 KB
Volume: 1
Category: Article
ISSN: 1936-5233
DOI: 10.1593/tlo.07100

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effect of combining aromatase inhibi

The effect of combining aromatase inhibitors with antiestrogens on tumor growth in a nude mouse model for breast cancer

✍ Qing Lu; Yang Liu; Brian J. Long; Dmitry Grigoryev; Mark Gimbel; Angela Brodie 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 101 KB

Evaluation of antitumor activity in a hu

Evaluation of antitumor activity in a human breast tumor/nude mouse model with a special emphasis on treatment dose

✍ Makoto Inaba; Tomowo Kobayashi; Tazuko Tashiro; Yoshio Sakurai; Koji Maruo; Yasu 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 503 KB

Eight lines of human breast tumors implanted in nude mice were treated with various antitumor agents at two different doses, maximum tolerated doses (MTD) and rational doses (RD) that were pharmacokinetically equivalent to the clinical doses; the response rates to both doses were compared. With MTD,

Combination of Oral Scutellaria Baicalen

Combination of Oral Scutellaria Baicalensis Extract and Intraperitoneal Cisplastin Suppresses Tumor Growth and Inhibits MTOR in a Mouse Breast Cancer Model

✍ M.N. Le; Y. Akmal; M. Senthil; J. Yan; Q. Xing; Y. Wang; D. Tully; J.H. Yim 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 54 KB

807: Combined treatment of pancreatic tu

807: Combined treatment of pancreatic tumour cells with bioactive food components reduces tumour growth and potentiates gemcitabine toxicity in a preclinical mouse model

✍ Dabernat, S.; Peuchant, E.; Moranvillier, I.; Rousseau, B.; Bedel, A.; Beliveau, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 64 KB

CXCR4 peptide antagonist inhibits primar

CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model

✍ Saima Hassan; Marguerite Buchanan; Kaushar Jahan; Adriana Aguilar-Mahecha; Louis 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 527 KB

## Abstract CXCR4 is a chemokine receptor implicated in the homing of cancer cells to target metastatic organs, which overexpress its ligand, stromal cell‐derived factor (SDF)‐1. To determine the efficacy of targeting CXCR4 on primary tumor growth and metastasis, we used a peptide inhibitor of CXCR